Aidence is a leading innovator in Artificial Intelligence for medical imaging, dedicated to empowering radiologists with cutting-edge software solutions. Their primary focus is on oncology, particularly lung cancer, where their Veye Lung Nodules AI tool aids in the early detection and tracking of pulmonary nodules. Since its acquisition by RadNet in January 2022, Aidence continues to advance AI technology to improve patient outcomes and streamline radiology workflows within RadNet's larger diagnostic imaging network.
Serves as the primary hub for research, development, and European operations for Aidence's AI medical imaging solutions, now integrated within RadNet's AI division.
Located within Amsterdam Science Park, a prominent European hub for scientific research, innovation, and technology companies, fostering a collaborative environment.
Aidence fosters a collaborative, innovative, and mission-driven work culture, focused on leveraging AI to make a significant impact in healthcare. There's an emphasis on research, continuous learning, and cross-functional teamwork, now contributing to RadNet's broader AI initiatives.
The Amsterdam office is significant as the birthplace of Aidence's core AI technology (like Veye Lung Nodules) and remains a key R&D center post-acquisition by RadNet, contributing to global advancements in medical AI.
Aidence's AI solutions, particularly Veye Lung Nodules, are utilized by hospitals and imaging centers primarily across Europe. Following its acquisition by RadNet, Aidence's technology is being integrated and scaled within RadNet's extensive network of imaging centers in the United States. Globally, Aidence's technology supports clinical decision-making in radiology, contributes to research collaborations, and aims to be deployed through partnerships to improve healthcare outcomes in various international markets.
Science Park 400
Amsterdam
North Holland
Netherlands
Address: 1510 Cotner Ave, Los Angeles, CA 90025, USA
Serves as the primary corporate hub for RadNet's extensive operations across the United States, influencing Aidence's market access, integration strategy, and broader AI development in North America.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Aidence' leadership includes:
Aidence has been backed by several prominent investors over the years, including:
Following its acquisition by RadNet, key Aidence leadership transitioned into significant AI roles within RadNet. In the past year, notable changes include the departure of Aidence's former CCO to a new opportunity, while other core Aidence leaders continue to drive AI strategy at RadNet. No major new executive hires specifically for the Aidence unit have been publicly announced recently.
Discover the tools Aidence uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While Aidence is now part of RadNet, historical email formats for Aidence staff likely followed common corporate patterns like 'firstname.lastname@aidence.com'. Post-acquisition, primary communication may utilize RadNet's email system for employees integrated into the parent company structure. For direct Aidence domain communications, the listed format is a common educated guess.
firstname.lastname@aidence.com
Format
jane.doe@aidence.com
Example
85%
Success rate
Radiology Business • May 10, 2024
RadNet reported significant progress in its AI division during Q1 2024, including the expansion of use cases for existing algorithms like those developed by Aidence for quantifying lung nodules. The company is also developing new AI tools and anticipates these will improve accuracy and efficiency in diagnostics....more
Aidence Website Blog • September 21, 2023
Aidence announced that its Veye Lung Nodules AI solution for pulmonary nodule management is now available on the Blackford Platform, increasing accessibility for healthcare institutions worldwide to integrate this technology into their existing workflows....more
RadNet, Inc. Press Release • January 20, 2022
RadNet, Inc. announced its acquisition of Aidence, a premier Dutch company in AI for pulmonary nodule detection and quantification on CT scans. This strategic acquisition aims to integrate Aidence's cutting-edge AI solutions into RadNet's extensive network of imaging centers....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Aidence, are just a search away.